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Objectives: To assess long-term trends in the volume of ambulatory antibiotic prescriptions and prescription
and consultation rates for respiratory tract infections (RTIs) in France in relation to the yearly public antibiotic
campaign since 2002.
Methods: Data collected on representative cohorts of office-based physicians and pharmacies in France parti-
cipating in IMS Health panels between 1980 and 2009 were analysed retrospectively. Main outcome measures
were antibiotic prescriptions per 1000 inhabitants per year (PIY), consultations per 1000 inhabitants per year
and proportion of consultations resulting in antibiotic prescriptions.
Results: The peak in ambulatory antibiotic prescriptions occurred in 1997 (1468 PIY). Although prescriptions
had decreased by 6% until 2001, prescriptions fell sharply (222%) between 2001 and 2004, followed by
stable prescription rates until 2009. The 2001–09 decrease in antibiotic prescriptions was driven by a sharp
decline in office-based antibiotic prescriptions (233%), exclusively achieved through a decrease in prescriptions
for RTIs. Consultations for RTIs steadily declined between 2001 and 2009 (223%), with the proportion of con-
sultations resulting in antibiotic prescriptions decreasing from 58% to 46%. Not all types of RTIs were equally
affected. The largest decrease in prescriptions was observed for nasopharyngitis and influenza. Rates for bron-
chitis, sinusitis, otitis media and tonsillitis remained persistently high.
Conclusions: During its first 3 years, the French public campaign accelerated a pre-existing decrease in ambu-
latory antibiotic prescriptions. The decrease in consultation rates suggests that altered illness behaviour of
patients may have contributed to the observed decline. The persistently high prescribing rates for certain
RTIs show that further effort is needed to improve antibiotic prescribing in France.
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Introduction
France is known for its high outpatient antibiotic consumption.1
In order to change this worrisome situation a yearly mass
media campaign has been conducted by the French National
Health Insurance each winter since autumn 2002. The aim of
this national campaign is to inform the public about appropriate
ambulatory antibiotic use, with a special focus on respiratory
tract infections (RTIs).2 The public campaign was complemented
by interventions targeting prescribers, such as academic
detailing, individual prescribing feedback and promotion of
rapid streptococcal antigen tests.2
In a recently published study, Sabuncu et al.2 analysed the
impact of the campaign using electronic data on individual pre-
scriptions provided by the French National Health Insurance, cov-
ering .90% of the population. They found a 26.5% decrease in
the total number of antibiotic prescriptions per 100 inhabitants
between 2000–02 and 2006–07.2 Little is known about the
impact of the campaign on prescribing and consultation rates
for specific indications, a common shortfall of campaigns to
improve antibiotic use, because these data are not easily avail-
able.3 This information seems, however, essential in order to
identify the most effective interventions and to adequately
plan future campaigns.4
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With this study we aimed to fill some of the gaps in the litera-
ture using validated databases provided by IMS Health to assess
trends in ambulatory antibiotic use in France over three decades,
including a detailed assessment of the evolution of prescription
and consultation rates for specific RTIs.
Methods
We compiled annual data regarding ambulatory antibiotic prescriptions
and related infectious diseases since 1980 in France, excluding its over-
seas departments, from IMS Health (Puteaux, France), including repre-
sentative panels of retail pharmacies [Le Marche´ Pharmaceutique (LMP),
compiled until 2001, and Suivi de la Dispensation Me´dicale (SDM), com-
piled since 1999] and office-based physicians [Enqueˆte Permanente sur
la Prescription Me´dicale (EPPM)]. IMS Health is an international
company which provides data on sales and medical activities mostly to
the pharmaceutical industry, but whose data are also exploited for
research purposes.5 – 8
Data from retail pharmacies
IMS Health France has been collecting sales data from retail pharmacies
for .35 years. Until 1999, sales data (LMP data) were exclusively
obtained from a representative panel of 450 retail pharmacies among
the 22500 pharmacies in metropolitan France whose reported drug pur-
chases (in packages) were extrapolated to the entire cohort of pharma-
cies. Packages were transformed into prescriptions by using EPPM data
regarding the number of packs per prescription (calculated for each
drug/package from physicians’ detailed information about the prescribed
drugs).
Since 1999, IMS Health has electronically collected daily prescriptions
and sales data from a much wider sample of retail pharmacies, the
number of which has increased continuously to .13500, now covering
60% of pharmaceutical sales in France (SDM data). The data are then
extrapolated to all 22500 pharmacies in France. The collected data
contain information about the prescribing physician, the prescribed and
dispensed drugs and dosages, and the patient.
Data derived from the EPPM and SDM panels are not expected to be
equivalent since physicians selected in the EPPM panel are exclusively
self-employed physicians without hospital or clinic activity.
Data from office-based physicians
The EPPM survey has been collecting data from a representative sample
of self-employed, office-based physicians (without hospital or clinic
activity) throughout France, on a quarterly basis for almost 40 years. In
each quarter, data are collected from a representative sample of 835
physicians (400 general practitioners and 435 specialists), selected
according to specialty, region, size of the urban setting and physician
age and gender, and annual consultation activity. A proportion of the
sample (115 doctors) is replaced in each quarter. Data are then extrapo-
lated to the entire population of physicians.
Data are collected during a period of 7 consecutive days, including a
copy of each prescription. Moreover, physicians fill out a survey form for
each patient containing information about socio-demographic character-
istics, the drugs prescribed (formulation, strength, daily dosage, duration
of therapy) and related presumed or confirmed diagnoses (labelled by
physicians with their own words), which are then compiled and classified
by IMS using ICD-9 (International Statistical Classification of Diseases and
Related Health Problems) and ICD-10 diagnostic codes (from 1998
onwards). Because of some discrepancies between ICD-9 and ICD-10
diagnostic coding, we continued to use ICD-9 codes for a few indications.
Reporting methods
Extrapolated data from all panels were normalized per 1000 inhabitants.
LMP and SDM data cover all ambulatory dispensed antibiotic prescrip-
tions, while EPPM provides data about antibiotic prescriptions, specific
diagnoses and consultation rates for office-based physicians only,
excluding other categories of physicians (e.g. physicians based in public
hospitals).
For the purpose of this study, all prescriptions of antibiotics belonging
to Anatomical Therapeutic Chemical Classification (ATC) group J01 (sys-
temic antibiotics; ATC version 2010) were included. We used descriptive
statistics and graphical displays to analyse trends in antibiotic prescrip-
tions and in consultation rates for specific diagnoses. Prescription pat-
terns and changes over time were monitored by calculating the
percentage of consultations for a specific diagnosis resulting in antibiotic
prescriptions. Data were aggregated for entire years. For the purpose of
validation, we compared the French IMS (SDM) data with European
Surveillance of Antibiotic Consumption (ESAC) data for the campaign
implementation period (2001–08). Because of the explorative nature of
this study, we did not perform hypothesis testing for statistical
significance.
Results
General analysis of trends
Figure 1 shows the evolution of antibiotic prescription rates
in France [prescriptions per 1000 inhabitants per year (PIY)]
between 1980 and 2009, stratified by total ambulatory prescrip-
tion rates (LMP and SDM data from retail pharmacies) and pre-
scription rates by self-employed office-based physicians only
(EPPM data).
Data from retail pharmacies
The data (Figure 1) show a steady increase in total ambulatory
antibiotic prescriptions from 1980 onwards, with a peak in
1997 (1468 PIY). Between 1997 and 2001 antibiotic prescription
rates declined by 5.9% (or on average 1.5% per year), preceding
a sharper decline between 2001 and 2004 (221.9% or 27.9%
per year), which coincided with the initial years of the antibiotic
campaign. After 2004, however, overall prescription rates
remained stable (+2.0% between 2004 and 2009). Examining
3 year average prescription rates (hence smoothing variable sea-
sonal effects), the results were similar:23.2% between 1996–98
and 1999–2001; 221.6% between 1999–2001 and 2004–06;
and +0.4% between 2004–06 and 2007–09. Similar trends
were observed when comparing data from IMS Health with
ESAC data, expressed as defined daily doses per 1000 inhabitants
per day (Figure 2).
Data from office-based physicians
Antibiotic prescription rates by self-employed office-based phys-
icians similarly increased until their peak in 1997 (Figure 1). From
1998 onwards they decreased continuously at a faster rate than
total ambulatory prescription rates: by 12.9% (23.4% per year)
between 1997 and 2001 (the year preceding the implementation
of the public campaign); by 26.0% (29.5% per year) between
2001 and 2004 (the initial years following its implementation);
and by 9.7% (22.0% per year) between 2004 and 2009.
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Analysis of trends in prescriptions according to type
of prescriber and infection
Between 2001 and 2009 prescription rates by office-based
doctors (physician-based EPPM data) fell by 33.1% to 577 PIY,
while overall ambulatory prescription rates (pharmacy-based
SDM data) were down 20.4% to 1118 PIY (Table 1). SDM data
confirmed that the 2001–09 decrease in antibiotic prescriptions
was limited to self-employed physicians (either office-based or
practising in private clinics), as ambulatory prescriptions issued
by physicians practising in public hospitals (+13.6%) and dentists
(+13.3%) increased slightly over that period. The decrease in
antibiotic prescription rates by office-based physicians between
2001 and 2009 was exclusively attributable to a decrease in pre-
scriptions for RTIs (239.9%), while prescriptions for other types
of infections (e.g. infections of the urinary and female genital
tract) remained almost stable (+4.6%; Table 1).
Analysis of trends in antibiotic prescriptions according
to age groups
Not all age groups were equally affected by the decrease in pre-
scriptions issued by office-based physicians (Figure 3). The
decrease was most marked for children aged ,15 years and
continued over the whole study period, because prescriptions
per 1000 children per year decreased by 32.1% from 2001 to
2004 and by a further 15.8% from 2004 to 2009. The overall
2001–09 decrease was similar in all three young age groups:
,2.5 years (242.6%); 2.5–7 years (243.3%); and 8–14 years
(244.4%). Antibiotic PIY for adolescents and adults
(15–64 years) declined by 31.1% between 2001 and 2009,
while in contrast prescriptions for the elderly (.65 years)
decreased only moderately (210.7%).
Analysis of trends in consultation and prescription
rates for RTIs
After excluding flu (for which annual consultation rates vary con-
siderably due to seasonal effects), antibiotic prescription rates for
RTIs (expressed as PIY) between 2001 and 2004 decreased to a
greater extent (by 232.3%) than the drop (211.4%) in patient
consultation rates for those RTIs, expressed as consultations
per 1000 inhabitants (Figure 4). The proportion of consultations
for RTIs resulting in antibiotic prescriptions overall fell from
58% in 2001 to 44% in 2004 (Figure 4). Of note, the decrease
in prescriptions for RTIs between 2001 and 2004 mostly resulted
from a steep decline in the proportion of consultations resulting
in antibiotic prescriptions for RTIs for which prescribing levels
were already relatively low, such as nasopharyngitis, pharyngitis
and flu (Figure 5). Prescribing levels decreased only modestly for
tonsillitis (from 93% to 87%), otitis media (from 80% to 74%),
acute bronchitis (from 80% to 73%) and sinusitis (from 84% to
83%; Figure 5).
Importantly, the decrease in antibiotic prescription rates for
RTIs after 2004 was mostly attributable to a decrease in consul-
tation rates (Figure 4). Antibiotic prescription rates for RTIs (other
than flu) decreased by 10.8% between 2004 and 2009. This was
mostly a consequence of a decrease in consultation rate
(213.4%), because the proportion of consultations for RTIs
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Figure 1. Changes in ambulatory antibiotic prescriptions per 1000 inhabitants per year in France between 1980 and 2009 according to the different
IMS data sources. LMP, data extrapolated from a representative panel of 450 retail pharmacies reporting their drug purchases; SDM, data extrapolated
from a panel of 13500 retail pharmacies reporting prescriptions dispensed to patients; EPPM, data extrapolated from a representative panel of 835
office-based doctors without hospital activity reporting detailed information about patients’ consultations, prescriptions and diagnoses.
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leading to antibiotic prescriptions increased slightly from 44% in
2004 to 46% in 2009 (Figure 4). After 2004, antibiotic prescrip-
tion rates remained more or less constant for all major RTIs,
and even bounced back for pharyngitis (from 17% in 2004 to
25% in 2008) and acute bronchitis (from 73% to 82%).
Discussion
This study assessed temporal trends in ambulatory antibiotic
usage in France from 1980 to 2009, and provides the following
important findings:
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Figure 2. Ambulatory antibiotic use in France expressed as defined daily doses (DDD) per 1000 inhabitants per day, 2001–08. Comparison between
data reported by the ESAC project and IMS pharmacy data obtained by converting dispensed packages into DDD (using the 2008 version of the WHO
ATC/DDD classification).
Table 1. Changes in number of ambulatory antibiotic prescriptions per 1000 inhabitants per year (PIY) in France between 2001 and 2009, stratified
by data source, category of prescribing physician and infection type
2001 2002 2003 2004 2005 2006 2007 2008 2009 Percentage change 2001/09
Pharmacy-based data (in PIY)
total ambulatory antibiotic prescriptions 1404 1260 1180 1096 1127 1096 1124 1090 1118 220.4
prescribed by dentists 80 89 89 89 88 90 91 91 91 +13.3
prescribed by public hospital-based physicians 73 75 73 72 74 77 80 81 83 +13.6
prescribed by self-employed physiciansa 1251 1096 1018 935 965 929 953 918 944 224.5
Physician-based data (in PIY)
total antibiotic prescriptions by office-based physiciansb 863 777 680 639 619 584 580 536 577 233.1
for RTIsc 689 598 512 466 443 411 410 377 414 239.9
for infections of the urinary and female genital tractc 58 60 57 60 59 63 61 59 61 +4.6
aSelf-employed doctors either based in retail offices or practising in private clinics.
bOffice-based doctors with no hospital/clinic activity.
cWhen diagnosis explicitly specified by doctors (i.e. in 95% of total prescriptions).
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(i) During its first 3 years, the French public campaign acceler-
ated a pre-existing decrease in ambulatory antibiotic pre-
scriptions after their peak in 1997.
(ii) After 2004, the impact of the campaign was limited.
(iii) Declining consultation rates for RTIs and the drop in anti-
biotic prescription rates for those infections contributed
equally to the overall decrease in antibiotic prescriptions
by office-based physicians between 2001 and 2009.
(iv) Decreased consultation rates for RTIs suggest altered illness
behaviour by patients.
(v) The decrease in antibiotic prescription rates by office-based
physicians for RTIs indicates that they also altered their
behaviour, yet they continue to frequently treat certain
RTIs with antibiotics unnecessarily.
These IMS Health data confirm those from the ESAC network
(Figure 2) and the French National Health Insurance published
by Sabuncu et al.2 and show an important reduction in antibiotic
use in France between 2001 and 2004, which correlates partially
with the French public campaign. Sabuncu et al.2 used the
winter seasons 2001 and 2002 to determine baseline prescribing
rates, thus limiting their ability to detect any secular trends exist-
ing before the intervention. It is unclear what caused the modest
decrease in antibiotic use before implementation of the antibiotic
campaign (between 1997 and 2001). Recommendations to
reduce antibiotic prescribing in the primary care setting in France
had already been issued in the mid-1990s. In addition, the par-
ticularly high antibiotic use in France compared with some of its
European neighbours and the problems associated with antibiotic
misuse became a frequent topic in the non-medical press by the
change of millennium, following the publication of an Official
Report to the Ministry of Health in May 1998. It is possible that
these factors already contributed to the observed pre-campaign
decrease. Most of the campaign effect occurred during the
period up to 2004, followed by a plateau with relatively stable anti-
biotic prescription rates. The French National Health Insurance
even noted a recent increasing trend in antibiotic use, which led
to the announcement of a modified campaign in 2010 with a
special focus on the risks of antimicrobial resistance.9 The
decrease in antibiotic prescriptions after implementation of the
campaign was more marked in children, which is consistent with
a campaign focusing on RTIs that are particularly common in
the paediatric population and specifically targeting parents of
young children. The staggered introduction of the conjugate pneu-
mococcal vaccine in 2003 in France may only have played a very
minor role in the reduction in prescriptions in this age group.
The physician-based EPPM data offer a unique perspective on
the quality of antibiotic prescribing not provided by other data
sources and show that the decline in antibiotic prescriptions
did not concern all RTIs equally. The decrease was most
marked for nasopharyngitis and influenza, for which prescribing
rates were already relatively low and even decreasing before
the campaign. This indicates that physicians might more easily
abandon unnecessary prescribing for infectious conditions that
are relatively easily recognizable as of viral origin, with a low
diagnostic uncertainty compared with acute bronchitis, which
continues to be a common cause of antibiotic prescribing
despite its frequent viral origin.10 – 12
Figure 3. Antibiotic prescriptions per 1000 inhabitants per year by office-based doctors (EPPM panel) in France, stratified by age groups for the years
2001, 2004 and 2009.
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Prescribing for acute tonsillitis was only marginally affected by
the decrease in antibiotic prescriptions (a shift from the diagnosis
of tonsillitis towards pharyngitis is unlikely since there was no
change in the relative frequency of the diagnoses pharyngitis
and tonsillitis). By contrast, the declines in consultation rates
for both tonsillitis and pharyngitis were greatest among all
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Figure 4. Consultations per 1000 inhabitants per year and proportion of consultations resulting in antibiotic prescriptions by office-based doctors
(EPPM) for RTIs other than flu in France, 1997–2009.
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RTIs. These data suggest that the part of the campaign targeting
the public may have been effective in persuading patients with
a sore throat not to seek medical attention, while physicians
only slightly improved their prescribing habit for this indication.
This is surprising since a considerable amount of money was
spent to distribute the rapid streptococcal antigen test and
train physicians in its use. A recently published study among
general practitioners in the Paris region confirms this assump-
tion, showing that the use of the rapid test was inconsistent
and decreased between 2005 and 2007.13 The reason for the
failure of many physicians to integrate this point-of-care test
into their clinical decision making is unclear, but diagnostic auto-
matisms probably play a role.
Importantly, consultation rates for RTIs were remarkably high
in France14,15 and decreased markedly over the period 2001–09,
explaining about one-half of the decrease in overall antibiotic
use by office-based physicians. This decrease was mostly attribu-
table to a three-quarter drop in the number of home visits by
office-based doctors for RTIs between 2001 and 2009 (data not
shown), with a 50% decrease over the 2001–04 period only. The
observed drop is in line with the published decrease in total
home visits in France by 30% between 2001 and 2003 and is
most likely an effect of the change in the reimbursement of
home visits by the French National Health Insurance introduced
in 2002, limiting the reimbursement to certain pre-defined indi-
cations and excluding minor illnesses.16 We assume that a small
proportion of these consultations have shifted to emergency
rooms, partly explaining the increase in outpatient antibiotic pre-
scriptions issued by hospitals. However, the magnitude of the
decline in consultations with office-based doctors suggests a suc-
cessful effect of the campaign that educated patients about the
self-limited nature of most RTIs (amplified by financial disincen-
tives) and implies that the altered illness behaviour of patients
might have contributed to the reduction in antibiotic use.
This analysis has limitations. EPPM data are derived from a
sample of office-based physicians and do not necessarily rep-
resent the prescribing behaviour of all physicians. The criteria
for physician selection into the panel remained constant over
time, hence possibly altering the relative weight of the rep-
resented population in overall medical activity. In addition, the
data are collected only for 1 week per trimester per physician,
limiting the degree to which the data can be extrapolated. Diag-
nostic uncertainty may have biased the classification of RTIs,
since reported diagnoses reflect physicians’ own perceptions
and labelling of diseases. Unfortunately, we were not able to
assess the specific impact of each individual intervention of the
multifaceted antibiotic campaign. Finally, we did not adjust our
analyses for seasonal variations in the incidence of influenza-like
illness, as done by others.2,17 However, when analysing trends
over extended time periods, this adjustment would probably
have changed the overall trends only slightly.
Despite these limitations, it should be noted that sales data
obtained from IMS Health have been used in previous studies
to evaluate antibiotic prescriptions in different countries.5 – 8 It
also has to be emphasized that the EPPM data together with
the SDM data on antibiotic prescriptions are mostly consistent
with the data from ESAC and the French National Health Insur-
ance, while having some additional strengths such as covering
an extended time period with physician-based data that are
not available otherwise.
What are the policy implications of these findings for France
and other countries? First, even though there seems to have
been a secular trend towards decreased antibiotic use even
before 2001, the public campaign was successful, since it was
associated with a rapid and marked reduction in antibiotic use,
at least in the initial years. There are, however, some caveats.
Even after the reduction in antibiotic use, France remains a
country with comparatively high antibiotic consumption; unfor-
tunately, the encouraging trend seems to have been reversed
in recent years.18 The potential reasons for this are most likely
complex and beyond the scope of this article.19 The data also
show that RTIs of frequent viral origin, such as bronchitis and
sinusitis, are still predominantly treated with antibiotics, leaving
ample room for improvement. Overall, our data show that
detailed evaluation of campaigns is necessary in order to identify
areas of success and failure and to guide future interventions.
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